MedPath

CO LETROZOLE

CO LETROZOLE

Discontinued
DIN Number

02352052

Drug Class

Human

Market Date

N/A

Company
HC

Cobalt Pharmaceuticals Company

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02352052
AIG Number0132937001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BG04 LETROZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

LETROZOLEActive
Strength: 2.5 MG
Monograph: LETROZOLE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.